Author:
Sideris S.,Aoun F.,Martinez C. N.,Latifyan S.,Awada A.,Costante G.,Gil T.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference83 articles.
1. Cancer Research (2015) http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/mortality . Accessed Aug 2015
2. Buchanan G, Irvine RA, Coetzee GA, Tilley WD (2001) Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 20:207–223
3. Oh WK, Hurwitz M, D’Amico AV, Richie JP, Kantoff PW (2003) Biology of prostate cancer. Holland-Frei Cancer Medicine, 6th edn. BC Decker, Hamilton, ON
4. Isikbay M, Otto K, Kregel S et al (2014) Glucocorticoid receptor activity contributes to resistance to androgen targeted therapy in prostate cancer. Horm Cancer 5:72–89
5. Perlmutter MA, Lepor H (2007) Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 9(1):S3–S8
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献